Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/08/2805515/0/en/Kriya-Provides-Update-on-Pipeline-Progress-Ahead-of-Company-Presentation-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/01/05/2804678/0/en/Kriya-Announces-Gene-Therapy-Program-for-Thyroid-Eye-Disease.html
https://www.globenewswire.com//news-release/2023/12/20/2799266/0/en/Kriya-to-Present-at-the-J-P-Morgan-42nd-Annual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/09/27/2750377/0/en/Kriya-Announces-Exclusive-License-and-Collaboration-Agreement-with-Everads-to-Advance-Gene-Therapies-for-Prevalent-Diseases-in-Ophthalmology-Including-Geographic-Atrophy.html
https://www.prnewswire.com/news-releases/everads-enters-license-agreement-with-kriya-for-development-of-ocular-gene-therapy-candidates-using-everads-suprachoroidal-delivery-technology-301940335.html
https://www.globenewswire.com//news-release/2023/09/06/2738391/0/en/Kriya-Acquires-Tramontane-Therapeutics-and-Launches-Gene-Therapy-Program-for-Nonalcoholic-Steatohepatitis-NASH-and-Other-Prevalent-Diseases.html
https://www.globenewswire.com/news-release/2023/07/26/2711290/0/en/Kriya-Announces-150-Million-Addition-to-its-Series-C-Bringing-Total-Round-to-over-430-Million-to-Further-its-Mission-of-Delivering-Gene-Therapies-for-Prevalent-Diseases.html
https://www.fiercebiotech.com/biotech/kriya-relies-ma-toolkit-once-more-build-out-internal-portfolio-time-neurology